Catalyst Pharmaceuticals, Inc. (CPRX)
22.80
+0.25
(+1.11%)
USD |
NASDAQ |
Dec 10, 16:00
22.80
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap: 2.802B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Collegium Pharmaceutical, Inc. | 1.545B |
| ACADIA Pharmaceuticals, Inc. | 4.536B |
| Amicus Therapeutics, Inc. | 3.039B |
| Rigel Pharmaceuticals, Inc. | 748.20M |
| United Therapeutics Corp. | 20.88B |
Market Cap Related Metrics
| PE Ratio | 13.30 |
| PS Ratio | 5.007 |
| PEG Ratio | 0.2878 |
| Price to Book Value | 3.045 |
| Price to Free Cash Flow | 12.34 |
| Price | 22.80 |
| Earnings Yield | 7.52% |
| PEGY Ratio | 0.2878 |
| Operating PE Ratio | 11.19 |
| Normalized PE Ratio | 13.49 |